D-0522-2022 Class III Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
February 9, 2022
Initiation Date
January 7, 2022
Termination Date
June 1, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6430 cartons

Product Description

Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42

Reason for Recall

Mislabeling

Distribution Pattern

USA Nationwide

Code Information

Lot#: 100018610, Exp 03/2022; 100021521, Exp 09/2022; 100024575, Exp 01/2023